3 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Sharon Riddler: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure a1DC + inactivated whole autologous HIV, a1DC + conserved HIV peptides, a1DC + no antigen - HIV Infections | Phase 1 | Completed | Sharon Riddler | 40 | 2019-01-02 | 2025-10-29 |
| Dipyridamole for Immune Activation in HIV Dipyridamole, Placebo, then Dipyridamole - HIV Infection | Phase 1 / Phase 2 | Completed | Sharon Riddler | 40 | 2014-07-01 | 2019-04-11 |
| Autologous Dendritic Cell Vaccine in HIV1 Infection Autologous HIV-1 ApB DC Vaccine - HIV Infections | Phase 1 / Phase 2 | Completed | Sharon Riddler | 11 | 2007-07-01 | 2025-11-06 |
HIV Infections (3) · Inflammation (1)
Dipyridamole (1)
United States (3)
Bernard Macatangay, MD (1) · John Mellors, MD (1) · Sharon A Riddler, MD MPH (1) · Sharon A. Riddler, MD, MPH (1)
U01AI110410 (1), U01AI131285 (1), U19AI055794 (1)